Two Cases of ALK-Altered Cancers of Unknown Primary Diagnosed by Immunohistochemistry

In this report, a rapid assessment by IHC led to alectinib treatment, which resulted in good outcomes in 2 cases of Lung-CUP. Alectinib was effective for ALK-altered Lung-CUPs.Case Rep Oncol 2022;15:21 –26
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research